Loading organizations...
§ Private Profile · Jiading, Shanghai, China
Innovative therapies and drugs for tumor treatment.
Juncell Therapeutics has raised $1.3M across 1 funding round.
Juncell Therapeutics has raised $1.3M in total across 1 funding round.
Juncell Therapeutics has raised $1.3M in total across 1 funding round.
Juncell Therapeutics's investors include bioVENTURE, Huaige Capital, Huangpu Medical Fund, Huayi Capital, Kaitai Capital.
Juncell Therapeutics has raised $1.3M across 1 funding round. Most recently, it raised $1.3M Series A in January 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 15, 2022 | $1.3M Series A | — | BioVenture, Huaige Capital, Huangpu Medical Fund, Huayi Capital, Kaitai Capital | Announced |